Product Images Losartan Potassium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Losartan Potassium NDC 71610-230 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a comparison between Atenolol and Losartan Potassium Tablets in terms of their effect on patients with fatal and non-fatal stroke. The table shows the percentages of patients in each group at different study months, along with the adjusted risk reduction percentage and p-value. The adjusted risk reduction for Losartan compared to Atenolol is 25% with a p-value of 0.001.*
This is a table showing the percentage of patients who had an event with and without Losartan Potassium Tablets, along with the risk reduction percentage and a numerical value (0.022). It appears to be a result of a clinical trial comparing Losartan Potassium Tablets with a placebo. No further information is available.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.